PRIVATE-LABEL INDUSTRY WILLING TO DISCUSS OTC TRADE DRESS ISSUES
This article was originally published in The Tan Sheet
Executive Summary
PRIVATE-LABEL INDUSTRY WILLING TO DISCUSS OTC TRADE DRESS ISSUES with manufacturers of branded over-the-counter products, Perrigo Chairman and CEO Michael Jandernoa told the Nonprescription Drug Manufacturers Association's marketing seminar Jan. 12 in New York City. Jandernoa alluded to the store-brand practice of marketing private-label products in packaging similar to branded OTCs, stating that "some of you view our [store-brand] products at times as going to a gray area" that "may exceed our right to package that product." Jandernoa assured the group, however, that private-label manufacturer Perrigo and "our industry is willing to sit down and talk with you if you have questions about the gray area of a package that you're concerned about."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning